PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Anesthesiology. Author manuscript; available in PMC Sep 1, 2010.
Published in final edited form as:
PMCID: PMC2756082
NIHMSID: NIHMS130174
Isoflurane Inhibits the Tetrodotoxin-resistant Voltagegated Sodium Channel Nav1.8
Karl F. Herold, M.D., Ph.D.,* Carla Nau, M.D. Ph.D., Wei Ouyang, Ph.D., and Hugh C. Hemmings, Jr., M.D., Ph.D.§
*Postdoctoral Associate, Department of Anesthesiology, Weill Cornell Medical College, New York, New York, and Department of Anesthesiology and Intensive Care Medicine, Charité-Universitaetsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany
Professor, Department of Anesthesiology, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany
Research Associate, Department of Anesthesiology, Weill Cornell Medical College, New York, New York
§Professor and Vice Chair of Research, Departments of Anesthesiology and Pharmacology, Weill Cornell Medical College, New York, New York
Address correspondence to Dr. Hemmings: Department of Anesthesiology, Box 50, LC-203, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065. hchemmi/at/med.cornell.edu Phone: 212-746-2714 Fax: 212-746-8316
Background
Voltage-gated sodium channels (Nav) mediate neuronal action potentials. Tetrodotoxin inhibits all Nav isoforms, but Nav1.8 and Nav1.9 are relatively tetrodotoxin-resistant (TTX-r) compared to other isoforms. Nav1.8 is highly expressed in dorsal root ganglion neurons and is functionally linked to nociception, but the sensitivity of TTX-r isoforms to inhaled anesthetics is unclear.
Methods
The sensitivities of heterologously expressed rat TTX-r Nav1.8 and endogenous tetrodotoxin-sensitive (TTX-s) Nav to the prototypic inhaled anesthetic isoflurane were tested in mammalian ND7/23 cells using patch-clamp electrophysiology.
Results
From a holding potential of −70 mV, isoflurane (0.53±0.06 mM, ~1.8 MAC at 24°C) reduced normalized peak Na+ current (INa) of Nav1.8 to 0.55±0.03 and of endogenous TTX-s Nav to 0.56±0.06. Isoflurane minimally inhibited INa from a holding potential of −140 mV. Isoflurane did not affect voltage-dependence of activation, but significantly shifted voltage-dependence of steady-state inactivation by −6 mV for Nav1.8 and by −7 mV for TTX-s Nav. IC50 values for inhibition of peak INa were 0.67±0.06 mM for Nav1.8 and 0.66±0.09 mM for TTX-s Nav; significant inhibition occurred at clinically relevant concentrations as low as 0.58 MAC. Isoflurane produced use-dependent block of Nav1.8; at a stimulation frequency of 10 Hz, 0.56±0.08 mM isoflurane reduced INa to 0.64±0.01 vs. 0.78±0.01 for control.
Conclusion
Isoflurane inhibited the tetrodotoxin-resistant isoform Nav1.8 with potency comparable to that for endogenous tetrodotoxin-sensitive Nav isoforms, indicating that sensitivity to inhaled anesthetics is conserved across diverse Nav family members. Block of Nav1.8 in dorsal root ganglion neurons could contribute to the effects of inhaled anesthetics on peripheral nociceptive mechanisms.
Voltage-gated Na+ channels (Nav) are critical to neuronal excitability, neurotransmitter release, and action potential initiation and propagation.1 These channels consist of a highly processed 260 kDa α-subunit that contains the ion channel pore formed by 4 homologous domains associated with auxiliary β-subunits (β1–β4) of 33–36 kDa.1 At least 9 α-subunits (Nav1.1–Nav1.9) have been identified, but the functional significance of the multiple isoforms is largely unclear.2 All Nav isoforms can be blocked by the puffer fish toxin tetrodotoxin, but three isoforms (Nav1.5, Nav1.8 and Nav1.9) are relatively resistant (200 to 10,000-fold less sensitive) compared to other isoforms.3,4 This suggests that pharmacological differences in anesthetic sensitivity might also apply to other drugs such as inhaled anesthetics.
Peripheral sensory neurons express both TTX-sensitive (TTX-s) (Nav1.1, Nav1.2, Nav1.6 and Nav1.7) and TTX-resistant (TTX-r) (Nav1.8 and Nav1.9) α-subunit isoforms.46 TTX-r Na+ currents found in dorsal root ganglion (DRG) neurons show distinctive biophysical properties, such as persistent and slowly inactivating currents.7 The persistent current has been attributed to Nav1.9, and the slowly inactivating current to Nav1.8.8,9 Nav1.8 is exclusively expressed in small-medium sized DRG neurons that give rise to C- and Aδ-fibers.4,10 These neurons play an important role in pain pathways as the majority of Nav1.8-containing afferents transmit nociceptive signals to the spinal cord.10 After peripheral nerve damage, functional expression of Nav1.8 decreases in injured neurons but is up-regulated in adjacent uninjured axons.11 Activation of uninjured neurons appears critical to the hyperalgesia seen in neuropathic pain states,12 and up-regulation of Nav1.8 in these neurons is an important component of this sensitization.11 Antisense oligonucleotides against Nav1.8 markedly reduce hyperalgesia and allodynia in animals with nerve injury.13 These findings support an important role for Nav1.8 in pain and identify it as an interesting target for the development of new analgesic drugs. Indeed, Nav1.8 has been reported to be 4-fold more sensitive to inhibition by lidocaine than the TTX-s channel Nav1.7.14
Halogenated inhaled (volatile) anesthetics inhibit endogenous TTX-s neuronal Na+ channels1517, including TTX-s Na+ channels in DRGs,18 as well as various Nav α-subunit isoforms heterologously expressed in mammalian cell lines19,20 or amphibian oocytes.21 Inhibition of presynaptic Na+ channels contributes to depression of neurotransmitter release by volatile anesthetics.2225 In contrast to the TTX-s isoforms tested, Nav1.8 expressed in Xenopus oocytes has been reported to be insensitive to inhaled anesthetics.21 Such reduced inhaled anesthetic sensitivity, opposite to that of local anesthetics,14 would have important implications for analgesic mechanisms and the structural basis of Na+ channel anesthetic sensitivity, and would be remarkable given the close sequence homologies between Na+ channel isoforms.2 We have therefore reexamined this more closely using a mammalian neuronal expression system.
In order to test the sensitivity of Nav1.8 to inhaled anesthetics under more physiological conditions we investigated the effects of the halogenated ether isoflurane on heterologously expressed TTX-r Nav1.8 and endogenously expressed TTX-s Nav in ND7/23 cells. Previous attempts to express Nav1.8 in non-neuronal mammalian cell lines for electrophysiological analysis have been unsuccessful.26,27 However the hybrid ND7/23 cell line derived from rat DRG neurons and a mouse neuroblastoma cell line (N18TG2) exhibits sensory neuron-like properties28 and can express functional heterologously transfected Nav1.8,27,2931 which probably reflects a requirement for additional subunits and/or a neuronal background for functional expression. In contrast to a previous report,21 transfected TTX-r Nav1.8, like endogenous TTX-s Nav isoforms, was inhibited by clinical concentrations of isoflurane.
Transient Transfection and Cell Culture
Rat Nav1.8-cDNA was subcloned into the mammalian expression vector pCMV-Script (Stratagene, La Jolla, CA) and the sequence of the entire Nav1.8 channel protein (NCBI nucleotide access number U53833) was verified by dideoxynucleotide sequencing. The ND7/23 rat DRG/mouse neuroblastoma fusion cell line was purchased from Sigma (Sigma-Aldrich, St. Louis, MO) and cultured in Dulbecco’s modified Eagle’s medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (Invitrogen), 2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin (Invitrogen) at 37°C under 95% air/5% CO2. Cells were grown on 12-mm glass coverslips in 35-mm polystyrene culture dishes and transiently transfected with rat Nav1.8-pCMV-Script (1–3 µg) and the pEGFP-N1 (Clontech, Mountain View, CA) reporter plasmid (0.5–1 µg) or reporter plasmid alone using Lipofectamine LTX (Invitrogen). At 48h after transfection, the transfected cells were identified by expression of enhanced green fluorescent protein (EGFP) using fluorescence microscopy. Average transfection efficiency was 60–70% for Nav1.8/EGFP. Untransfected ND7/23 cells were plated and seeded as described above and incubated for 48h to study endogenous TTX-s Na+ channels.
Electrophysiological Technique and Recordings
Coverslips containing ND7/23 cells were transferred into a small-volume open bath perfusion chamber (Warner Instruments, Hamden, CT) and continuously perfused with external solution containing (in mM): 129 NaCl, 10 HEPES, 3.25 KCl, 2 MgCl2, 2 CaCl2, 20 tetraethylammonium-Cl, 5 D-glucose, 0.0003 tetrodotoxin (Sankyo Kasei Co., Tokyo, Japan), adjusted to pH 7.4 (with NaOH) and 310 mOsm/kg H2O. Voltage-clamp recordings were performed at room temperature (23–24°C) in standard whole-cell configuration32 using an Axopatch 200B patch-clamp amplifier (Molecular Devices, Sunnyvale, CA). Experiments were performed at room temperature to minimize anesthetic losses, maximize recording stability, and facilitate comparisons to other studies of isoflurane on Na+ currents. Fire-polished patch pipettes were pulled from borosilicate glass capillaries (Warner Instruments) using a Sutter P-97 puller (Sutter Instruments, Novato, CA) and had a resistance of 1–.02.0 MΩ when filled with the following internal pipette solution (in mM): 120 CsF, 10 NaCl, 10 HEPES, 11 EGTA, 10 tetraethylammonium-Cl, 1 CaCl2, 1 MgCl2, adjusted to pH 7.3 (with CsOH) and 315 mOsm/kg H2O.
Currents were low-pass filtered at 5 kHz and sampled at 20 kHz. Capacitive transients were electronically cancelled and voltage errors were minimized using 70–80% series resistance compensation. Series resistance was typically 1–5 MΩ, and recordings were discarded if resistance exceeded 8 MΩ. Initial seal after establishing the whole-cell patch was 2–4 GΩ, and recordings were discarded if the seal dropped below 1 GΩ. Liquid junction potential was not corrected. Linear leakage currents were digitally subtracted on-line by the P/4 protocol (except for inactivation and use-dependent experiments).
Isoflurane-saturated external solutions (containing 12–12.5 mM isoflurane) were prepared by shaking in gas-tight glass vials for 24h as previously described.16 This stock solution was further diluted on the day of the experiment into gas-tight glass syringes, from which a sample was taken for determination of aqueous isoflurane concentration by gas chromatography. Solutions were perfused focally onto recorded cells via a 150-µm diameter perfusion pipette using polytetrafluoroethylene tubing to minimize isoflurane loss. Perfusate samples were also taken to determine isoflurane concentrations at the tip of the perfusion manifold, and reflected ~10% loss that occured from the syringe through the tubing to the pipette tip. Isoflurane concentrations were determined by extraction into n-heptane (1:1 v/v) followed by analysis using a Shimadzu GC-8A gas chromatograph (Shimadzu, Tokyo, Japan) with external standard calibration as described.16,20 Isoflurane solution flow of 0.05 ml/min was controlled by a pressurized perfusion system (ALA Scientific, Westbury, NY).
Stimulation Protocols and Data Analysis
The holding potential (Vh) used was either −70 mV or −140 mV. To analyze the voltage-dependence of activation, currents were evoked by 5-ms pulses ranging from −80 to +70 mV in steps of 10 mV. The conductance (GNa) was calculated using the equation: GNa=INa/(Vm−Vrev), where INa is peak current, Vm the test potential and Vrev the calculated reversal potential (+65 mV). Normalized conductance (G/Gmax) was plotted against test potentials and fitted to the Boltzmann function: G/Gmax=1/[1+exp(V1/2−V/k)], where V1/2 is the voltage that elicits half-maximal activation and k is the slope factor. Steady-state and fast inactivation were measured by applying a double-pulse protocol that consisted of a 500 ms (h) or 15 ms (fast inactivation) prepulse ranging from −120 to +20 mV in steps of 10 mV, followed by a test pulse to +10 mV (Nav1.8) or −10 mV (TTX-s Nav). Peak currents of the test pulse were measured, normalized (INa/INamax), plotted against the prepulse potential and fitted with a Boltzmann function. Decay time constants of peak INa were obtained from a monoexponential fit to the decay phase of the macroscopic Na+ current from 90% of peak current. Use-dependent block for Nav1.8 was studied at 1 Hz, 3 Hz and 10 Hz with 60 10 ms test pulses up to a final potential of +10 mV. Peak currents were measured, normalized to the first pulse and plotted against pulse number. IC50 values were determined by least squares fitting of data to the Hill equation: Y=1/(1+10((logIC50 − X)h)), where Y is the current amplitude, X is the isoflurane concentration and h is Hill slope. Statistical significance was assessed by analysis of variance with Newman-Keuls post hoc test, or paired or unpaired student t-test. P < 0.05 was considered statistically significant. The programs used for data acquisition and analysis were pClamp 10 (Axon/Molecular Devices), Excel (Microsoft Inc., Redmond, WA) and Prism 5 (GraphPad Software Inc., San Diego, CA). Values are reported as mean±SEM unless otherwise stated.
Properties of Na+ Currents in Wild-type and Nav1.8-transfected Cells
ND7/23 cells express endogenous TTX-s Na+ currents (INa) with properties similar to TTX-s currents in isolated DRG neurons.27 Though the specific Na+ channel isoforms responsible for TTX-s currents in ND7/23 cells are unknown, DRG neurons express a mixed population of Na+ channels that includes Nav1.1, Nav1.2, Nav1.6 and Nav1.7.5,6,33 We compared the effects of isoflurane on endogenously expressed TTX-s INa in untransfected ND7/23 cells and on TTX-r INa in ND7/23 cells transiently transfected with rat Nav1.8 in the presence of 300 nM tetrodotoxin to block endogenous TTX-s INa, since Nav1.8 is resistant to tetrodotoxin (IC50 > 100 µM).3 ND7/23 cells expressed voltage-gated TTX-s INa (−1620±880 pA at Vh=−70 mV, n=6; −2220±680 pA at Vh=−140 mV, n=6, mean±SD) that rapidly activated and inactivated upon depolarization (Figure 1A, left). These Na+ currents were completely inhibited by 300 nM tetrodotoxin, indicating that ND7/23 cells do not express detectable endogenous TTX-r Na+ channels (Figure 1A, right). ND7/23 cells transfected with Nav1.8 α-subunit showed prominent voltage-gated TTX-r INa (−1830±840 pA at Vh=−70 mV, n=8; −1920±620 pA at Vh=−140 mV, n=8, mean±SD) in the presence of 300 nM tetrodotoxin (Figure 1B).30 Transfection of EGFP alone did not result in expression of TTX-r INa (data not shown).
Figure 1
Figure 1
Representative voltage-clamp recordings of Na+ currents. A) Tetrodotoxin-sensitive Na+ currents endogenously expressed in an ND7/23 cell in the absence (left) or presence (right) of 300 nM tetrodotoxin, which is sufficient to block all tetrodotoxin-sensitive (more ...)
Effect of Isoflurane on Peak Current and Activation
Current-voltage relationships were determined for TTX-r Nav1.8 and TTXs Nav at the physiological holding potential of −70 mV (Figure 2). Peak INa was activated at a command potential of +10 mV for TTX-r Nav1.8 and −10 mV for TTX-s Nav. At a concentration of isoflurane (0.53±0.06 mM) equivalent to ~1.8 MAC [minimal alveolar concentration] in rat after temperature correction to 24°C,34,35 the normalized peak INa was 0.55±0.03 for TTX-r Nav1.8 (n=8) and 0.56±0.06 for TTX-s Nav (n=6) (Figure 2A). Inhibition was reversible upon washout of isoflurane (data not shown). Normalized conductance (G/Gmax) plotted against command potential indicated no significant effects of isoflurane on voltage-dependence of activation for TTX-r Nav1.8 or TTX-s Na+ currents (Figure 2B, Table 1). From a more hyperpolarized holding potential of −140 mV at which most channels are in the closed resting state, isoflurane was much less effective and reduced normalized peak INa to 0.91±0.03 for TTX-r Nav1.8 (n=8) and to 0.91±0.01 for TTX-s Nav (n=6) (Figure 3). There was no significant effect of isoflurane on the voltage-dependence of activation of TTX-r Nav1.8 or TTX-s Nav from either holding potential (for V1/2 and k values, see Table 1). Further analysis of time-to-peak values, the interval from the beginning of the test pulse to peak INa amplitude, also showed no significant difference between control and isoflurane for TTX-r Nav1.8 and TTX-s Nav (data not shown).
Figure 2
Figure 2
Current-voltage relationships and voltage-dependence of activation for tetrodotoxin-resistant (TTX-r) Nav1.8 (left) and tetrodotoxin-sensitive (TTX-s) Nav (right) currents performed in the absence or presence of isoflurane. Whole-cell currents were evoked (more ...)
Table 1
Table 1
Parameters for Na+ current activation and inactivation
Figure 3
Figure 3
Current-voltage relationships and voltage-dependence of activation for tetrodotoxin-resistant (TTX-r) Nav1.8 (left) and tetrodotoxin-sensitive (TTX-s) Nav (right) currents performed in the absence or presence of isoflurane. Whole cell currents were evoked (more ...)
Effect of Isoflurane on Inactivation
The voltage-dependence of Na+ channel inactivation was studied using a two-pulse protocol that consisted of a series of command potentials from −120 mV to +20 mV in 10 mV steps, followed by a test pulse to elicit peak INa (+10 mV for TTX-r Nav1.8 and −10 mV for TTX-s Nav). This standard approach assesses the fraction of channels available for activation by the second pulse. As the membrane potential of the pre-pulse becomes more positive, more channels enter inactivated and non-conducting states such that fewer channels are available for activation by the second test pulse. Inactivation curves were determined using two different pre-pulse durations; fast inactivation was measured using a 15 ms pre-pulse27 and steady-state inactivation using a 500 ms pre-pulse (Figure 4). The INa of the second test pulse was normalized to peak INa (INa/INamax), plotted against pre-pulse potential, and fitted to a standard Boltzmann function from which the voltage of half-inactivation (V1/2) was determined (Table 1). Isoflurane (0.53±0.06 mM) produced a negative shift in the voltage-dependence of steady-state inactivation (500 ms prepulse) of −5.6±0.8 mV for TTX-r Nav1.8 and −7.1±0.3 mV for TTX-s Nav (P < 0.001), and a negative shift in the voltage-dependence of fast inactivation (15 ms prepulse) of −9.2±2.1 mV for TTX-r Nav1.8 and −15±2.3 mV for TTX-s Nav (P < 0.01). There were no significant effects on slope values. The time constant of Na+ current decay at peak INa (τ) was significantly increased by isoflurane for both TTX-r Nav1.8 and TTX-s Nav. The τ values for Nav1.8 were 2.5 ± 0.1 ms in control and 3.0 ± 0.2 ms with isoflurane (P < 0.05, n=8), and for TTX-s Nav were 0.54 ± 0.04 ms in control and 0.58 ± 0.04 ms with isoflurane (P < 0.05, n=6).
Figure 4
Figure 4
Inactivation of tetrodotoxin-resistant (TTX-r) Nav1.8 (A, B; n=8) and tetrodotoxin-sensitive (TTX-s) Nav (C, D; n=4) Na+ currents. Peak Na+ current (INa) was normalized to the maximal value (INamax) and plotted against the conditioning pulse potential. (more ...)
IC50 values for isoflurane inhibition of INa were obtained by eliciting peak INa from a holding potential of −70 mV. Normalized peak INa values were fitted to the Hill equation to yield IC50 and Hill slope values (Figure 5). The IC50 values of 0.67±0.06 mM for TTX-r Nav1.8 and 0.66±0.09 mM for TTX-s Nav, and Hill slopes of −1.12±0.16 for TTX-r Nav1.8 and −0.85±0.14 for TTX-s Nav were not significantly different. Significant inhibition occurred at isoflurane concentrations as low as 0.17 ± 0.01 mM (equivalent to 0.58 MAC after temperature correction to 24°C) for both TTX-r Nav1.8 (P < 0.01; n=6) and TTX-s Nav (P < 0.001; n=8).
Figure 5
Figure 5
Concentration-dependence for inhibition of tetrodotoxin-resistant (TTX-r) Nav1.8 (A) and tetrodotoxin-sensitive (TTX-s) Nav (B) by isoflurane. Left panels show representative traces of TTX-r Nav1.8 (A) or TTX-s Nav (B) Na+ currents in the absence (control (more ...)
Voltage-dependent Block of Nav1.8
At the physiological holding potential of −70 mV, isoflurane (0.53±0.05 mM) significantly reduced the normalized peak INa to 0.55±0.03 for TTX-r Nav1.8 (P < 0.001, n=8) and to 0.56±0.06 for TTX-s Nav (P < 0.01, n=5) (Figure 6). Inhibition by isoflurane was significantly less from a holding potential of −140 mV, at which most channels are in the closed resting state (normalized peak INa was 0.91±0.03 (P < 0.05, n=8) for TTX-r Nav1.8 and 0.91±0.01 (P < 0.001, n=6) for TTX-s Nav).
Figure 6
Figure 6
Voltage-dependent effects of isoflurane on inhibition of peak INa. tetrodotoxin-resistant Nav1.8 (closed bars) and tetrodotoxin-sensitive (TTX-s) Nav (open bars) Na+ currents were inhibited strongly by isoflurane (0.53±0.06 mM, equivalent to ~1.8 (more ...)
Use-dependent Block of Nav1.8
Preferential interaction of isoflurane with the inactivated state of Na+ channels results in accumulation of drug-bound channels during high-frequency stimulation.36 Native TTX-r Na+ channels found in DRG neurons recover quickly from inactivation after membrane repolarization,37 and similar behavior has been reported for Nav1.8 in ND7/23 cells.30 We used 60 pulses to +10 mV to determine the decay in peak amplitude of Nav1.8 at various frequencies (1, 3 and 10 Hz). In control experiments use-dependent block was more pronounced at higher stimulation frequencies (Figure 7). In the presence of isoflurane (0.56±0.08 mM), Nav1.8 currents showed a greater use-dependent decrement compared to control at all three stimulation frequencies tested. At a stimulation frequency of 1 Hz, the plateau of normalized peak INa, which was determined by fitting the data to a single exponential function, was 0.94±0.01 in control and 0.85±0.02 in the presence of isoflurane (p<0.001, n=5). At a stimulation frequency of 3 Hz, the plateau of normalized peak INa was 0.88±0.01 in control and 0.81±0.01 in the presence of isoflurane (p<0.001, n=5). At the highest frequency of 10 Hz, the plateau of normalized peak INa was 0.78±0.01 in control and 0.64±0.01 in the presence of isoflurane (p<0.001, n=5). Control data for use-dependent reductions in Nav1.8 current are comparable to those published previously for this channel.27,30
Figure 7
Figure 7
Use-dependent block of tetrodotoxin-resistant Nav1.8 currents in the absence (control, open symbols) or presence (closed symbols) of isoflurane (0.56±0.08 mM; ~1.6 MAC). Whole-cell currents were evoked by 60 step depolarization commands (holding (more ...)
Voltage-gated Na+ channel isoforms are pharmacologically distinguishable, and are in fact classified, by their differential sensitivities to the specific inhibitor tetrodotoxin. Considerable evidence indicates that TTX-s isoforms are reversibly inhibited by clinical concentrations of volatile anesthetics, but anesthetic effects on the TTX-r isoforms are poorly characterized. A prior study suggested that Nav1.8 was unique among Nav isoforms tested in its resistance to inhibition by isoflurane when tested using heterologous expression in amphibian oocytes,21 but this has not been confirmed in neuronal cells. We investigated the effects of the commonly used inhaled anesthetic isoflurane on endogenously expressed TTX-s and heterologously expressed TTX-r Nav1.8 currents in a neuronal cell line.
Isoflurane inhibited both TTX-r Nav1.8 and endogenous TTX-s Nav with similar potencies (IC50 = 0.67 mM or 0.66 mM, respectively). These concentrations correspond to ~2.3 MAC in rat after temperature correction to 24°C, and are similar to those reported previously for inhibition of Nav1.2, Nav1.4 and Nav1.5 heterologously expressed in Chinese hamster ovary cells by isoflurane (IC50 = 0.70, 0.61, and 0.45 mM, respectively).20 Although the IC50 values are somewhat higher than clinically relevant concentrations, significant inhibition occurs in the more clinically relevant concentration range of >0.5 times MAC.20,24,38 Moreover, small reductions in INa can have large physiological effects due to nonlinear coupling.24 The finding that isoflurane inhibits Nav1.8 expressed in a mammalian neuronal cell line but not when expressed in Xenopus oocytes21 demonstrates the importance of an appropriate expression system for pharmacological studies of these channels.
It is now clear that both TTX-r and TTX-s Nav isoforms are inhibited by inhaled anesthetics and do not exhibit major differences in anesthetic sensitivity.20 Sensitivity to inhaled anesthetics is even present in the homologous prokaryotic Na+ channel NaChBac, indicating that anesthetic sensitivity is related to a fundamental evolutionarily conserved Na+ channel property.39 In addition to their differential sensitivities to tetrodotoxin, Nav isoforms have been reported to have different sensitivities to local anesthetics. In rat DRG neurons and with oocyte expression, TTX-r currents (primarily Nav1.8) are more sensitive to inhibition by lidocaine than TTX-s channels despite their highly conserved amino acid sequences.7,14 Sensitivity of Nav isoforms to local anesthetics is determined primarily by conserved residues in the DIV-S6 segment,40 while the greater sensitivity of Nav1.7 and Nav1.8 to lidocaine has been proposed to result from minor sequence differences in the DI and DII S6 segments,14 although this could be affected by differences in voltage dependence of inactivation. The comparable sensitivities of various Nav isoforms to isoflurane suggest a conserved drug binding domain, perhaps in DIV-S6.
Analysis of Nav1.8 pharmacology has been hampered by difficulties in expressing functional channels. Initial expression in Xenopus oocytes showed relatively small currents,4 and attempts by other groups to express Nav1.8 in mammalian cell lines including COS-7,41 CHO42 and HEK-293 cells27 resulted in very low levels of functional expression. However ND7/23 cells, derived from rat DRG and mouse neuroblastoma (N18TG2) cells, are suitable for transient and stable expression of recombinant Nav1.8 in a mammalian neuronal environment.28 These cells endogenously express Nav β1- and β3-subunits,27 which are sufficient for the functional expression and stability of Nav1.8 β-subunits. Co-transfection of Nav1.8 with the β1-subunit29 or β3-subunit27 does not alter current kinetics, activation or inactivation characteristics of TTX-r currents in ND7/23 cells.
Isoflurane had negligible effects on the voltage dependence of Nav1.8 activation, but produced a hyperpolarizing shift in the voltage-dependence of fast and steady-state inactivation. This behavior is consistent with selective interaction of isoflurane with channels in the inactivated state as described previously for other Na+ channel isoforms including Nav1.2 and Nav1.4.1921 The molecular basis of this block has yet to be determined for volatile anesthetics. Our results suggest that the shift in voltage-dependence of inactivation might result from slowing of inactivation evidenced by the increased time constants of current decay. The functional consequence is a reduction in the range of membrane potentials over which Nav1.8 can operate, as confirmed by the voltage-dependence of isoflurane inhibition.
Other Na+ channel blockers such as local anesthetics (e.g. lidocaine) and certain anticonvulsants and anti-arrhythmics also exhibit state-dependent drug interactions with Nav as described by the modulated receptor hypothesis.43 Voltage-dependent block by local anesthetics results in a hyperpolarizing shift in steady-state inactivation, thus enhancing channel block at normal as opposed to hyperpolarized potentials. Isoflurane apparently inhibits Na+ channels by a similar mechanism involving enhanced inactivation. Selective interaction with inactivated states is consistent with the use-dependent block by isoflurane, which increases the fraction of channels in the inactivated state. Na+ channels undergo both fast and slow inactivation, and slow inactivation contributes to the use-dependent effects of some drugs.44 The contribution of slow inactivation to the effects general anesthetics on Nav block is an interesting question for future investigation.
The rate at which Na+ channels recover from inactivation (repriming) determines how well channels respond to high firing rates. Isoform-specific differences in repriming rate have been reported.45 Interestingly, repriming rates of TTX-r Na+ currents, which are 'slow' in terms of time to peak current and time constant of current decay, are about ten-fold faster than those of TTX-s Na+ currents in rat DRG neurons. Use-dependent block of Nav1.8 by isoflurane could be due to its slow dissociation from blocked channels during repolarization, effectively slowing the repriming rate, but this is unlikely given the low affinity interaction. Lidocaine does not interfere with movement of the cytoplasmic inactivation loop, which is the underlying mechanism for fast inactivation, such that lidocaine-induced slowing of Na+ channel repriming does not result from slow recovery of the fast-inactivation gate.46 This suggests that use-dependent block does not involve accumulation of fast-inactivated channels, but could involve effects on slow inactivation mechanisms. By analogy with local anesthetics, stabilization of inactivated channel states and/or open channel block by isoflurane is currently a more plausible explanation.38
The Na+ current underlying the depolarization phase of the action potential in nociceptive DRG neurons is carried primarily by Nav1.8, which is expressed exclusively in this cell type.4,10 Slowly inactivating TTX-r Na+ currents are eliminated in DRG neurons of Nav1.8 knock-out mice, which confirms the role of Nav1.8 in conducting these currents.8 Both antisense and knock-out studies support a role for Nav1.8 activation in inflammatory pain.8 Previous studies using antisense nucleotides suggested a role for Nav1.8 in neuropathic pain,13 but a recent study shows that Nav1.8 is necessary for mechanical, cold and inflammatory pain, but not for neuropathic and heat pain.47 Visceral pain, a major consideration in the peri-operative setting, has been attributed to Nav1.8 since knock-out mice show decreased visceral pain and referred hyperalgesia.48 Subanesthetic concentrations of isoflurane, which would probably have relatively small effects on Nav1.8, depress the nociceptive reflex to single electrical stimuli in humans,49,50 while anesthetic concentrations of ~1 MAC are required to depress the response to repetitive stimuli critical to central hyperexcitability in humans.49,50 In addition, volatile anesthetics including isoflurane significantly suppress development of spinal sensitization in the rat paw formalin test, which has implications for the development of postoperative pain.51 Moreover, isoflurane has peripheral antinociceptive effects in a number of animal models in which supraspinal modulatory and/or pronociceptive effects were surgically or pharmacologically eliminated.5254 The anesthetic concentrations required for these effects on pain processing are consistent with the sensitivity of Nav1.8 to inhibition by isoflurane and a possible role in nociceptive processing by DRG neurons. This inhibition would be enhanced at high firing frequencies and depolarized membrane potentials, conditions that occur with tissue injury and inflammation, based on the frequency- and voltage-dependence of isoflurane block. Recent studies also implicate volatile anesthetic activation and sensitization of TRPV1 ion channels in lowering the threshold for heat activation.55 Anesthetic modulation of peripheral Na+ channels such as Nav1.8 therefore has the potential to modulate these poorly characterized pronociceptive mechanisms. The role of isoflurane inhibition of Nav1.8 in acute perioperative pain and the development of hyperexcitability is an interesting topic for further investigation.
In conclusion, both TTX-r Nav1.8 and TTX-s Nav were inhibited by isoflurane at concentrations that occur during clinical anesthesia. This is consistent with a conserved drug-binding site among various Nav isoforms. The critical role of Nav1.8 in peripheral pain mechanisms suggests that its inhibition could contribute to the antinociceptive and possibly anti-inflammatory effects of isoflurane and other inhaled anesthetics capable of blocking these channels.
Acknowledgments
Received from the Department of Anesthesiology, Weill Cornell Medical College, New York, New York. Supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG HE4554/5-1, K.F.H.), Bonn, Germany and by the National Institutes of Health (GM58055, H.C.H.), Bethesda, Maryland, United States of America.
Footnotes
Summary Statement: Isoflurane inhibits tetrodotoxin-resistant and tetrodotoxin-sensitive voltage-gated Na+ channels, consistent with a conserved interaction site with inhaled anesthetics in all Na+ channel isoforms. Effects on Nav1.8 could contribute to modulation by inhaled anesthetics of peripheral nociception.
1. Catterall WA. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron. 2000;26:13–25. [PubMed]
2. Goldin AL, Barchi RL, Caldwell JH, Hofmann F, Howe JR, Hunter JC, Kallen RG, Mandel G, Meisler MH, Netter YB, Noda M, Tamkun MM, Waxman SG, Wood JN, Catterall WA. Nomenclature of voltage-gated sodium channels. Neuron. 2000;28:365–368. [PubMed]
3. Goldin AL. Resurgence of sodium channel research. Annu Rev Physiol. 2001;63:871–894. [PubMed]
4. Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature. 1996;379:257–262. [PubMed]
5. Benn SC, Costigan M, Tate S, Fitzgerald M, Woolf CJ. Developmental expression of the TTX-resistant voltage-gated sodium channels Nav1.8 (SNS) and Nav1.9 (SNS2) in primary sensory neurons. J Neurosci. 2001;21:6077–6085. [PubMed]
6. Waxman SG, Cummins TR, Dib-Hajj S, Fjell J, Black JA. Sodium channels, excitability of primary sensory neurons, and the molecular basis of pain. Muscle Nerve. 1999;22:1177–1187. [PubMed]
7. Roy ML, Narahashi T. Differential properties of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in rat dorsal root ganglion neurons. J Neurosci. 1992;12:2104–2111. [PubMed]
8. Akopian AN, Souslova V, England S, Okuse K, Ogata N, Ure J, Smith A, Kerr BJ, McMahon SB, Boyce S, Hill R, Stanfa LC, Dickenson AH, Wood JN. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci. 1999;2:541–548. [PubMed]
9. Cummins TR, Dib-Hajj SD, Black JA, Akopian AN, Wood JN, Waxman SG. A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons. J Neurosci. 1999;19:RC43. (Rapid Communication) [PubMed]
10. Djouhri L, Fang X, Okuse K, Wood JN, Berry CM, Lawson SN. The TTX-resistant sodium channel Nav1.8 (SNS/PN3): expression and correlation with membrane properties in rat nociceptive primary afferent neurons. J Physiol. 2003;550:739–752. [PubMed]
11. Gold MS, Weinreich D, Kim CS, Wang R, Treanor J, Porreca F, Lai J. Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain. J Neurosci. 2003;23:158–166. [PubMed]
12. Jang JH, Kim KH, Nam TS, Lee WT, Park KA, Kim DW, Leem JW. The role of uninjured C-afferents and injured afferents in the generation of mechanical hypersensitivity after partial peripheral nerve injury in the rat. Exp Neurol. 2007;204:288–298. [PubMed]
13. Porreca F, Lai J, Bian D, Wegert S, Ossipov MH, Eglen RM, Kassotakis L, Novakovic S, Rabert DK, Sangameswaran L, Hunter JC. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc Natl Acad Sci USA. 1999;96:7640–7644. [PubMed]
14. Chevrier P, Vijayaragavan K, Chahine M. Differential modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by the local anesthetic lidocaine. Br J Pharmacol. 2004;142:576–584. [PubMed]
15. Ouyang W, Wang G, Hemmings HC., Jr Isoflurane and propofol inhibit voltage-gated sodium channels in isolated rat neurohypophysial nerve terminals. Mol Pharmacol. 2003;64:373–381. [PubMed]
16. Ratnakumari L, Hemmings HC., Jr Inhibition of presynaptic sodium channels by halothane. Anesthesiology. 1998;88:1043–1054. [PubMed]
17. Ratnakumari L, Vysotskaya TN, Duch DS, Hemmings HC., Jr Differential effects of anesthetic and nonanesthetic cyclobutanes on neuronal voltage-gated sodium channels. Anesthesiology. 2000;92:529–541. [PubMed]
18. Scholz A, Appel N, Vogel W. Two types of TTX-resistant and one TTX-sensitive Na+ channel in rat dorsal root ganglion neurons and their blockade by halothane. Eur J Neurosci. 1998;10:2547–2556. [PubMed]
19. Rehberg B, Xiao YH, Duch DS. Central nervous system sodium channels are significantly suppressed at clinical concentrations of volatile anesthetics. Anesthesiology. 1996;84:1223–1233. discussion 27A. [PubMed]
20. Ouyang W, Hemmings HC., Jr Isoform-selective effects of isoflurane on voltage-gated Na+ channels. Anesthesiology. 2007;107:91–98. [PubMed]
21. Shiraishi M, Harris RA. Effects of alcohols and anesthetics on recombinant voltage-gated Na+ channels. J Pharmacol Exp Ther. 2004;309:987–994. [PubMed]
22. Schlame M, Hemmings HC., Jr Inhibition by volatile anesthetics of endogenous glutamate release from synaptosomes by a presynaptic mechanism. Anesthesiology. 1995;82:1406–1416. [PubMed]
23. Westphalen RI, Hemmings HC., Jr Selective depression by general anesthetics of glutamate versus GABA release from isolated cortical nerve terminals. J Pharmacol Exp Ther. 2003;304:1188–1196. [PubMed]
24. Wu XS, Sun JY, Evers AS, Crowder M, Wu LG. Isoflurane inhibits transmitter release and the presynaptic action potential. Anesthesiology. 2004;100:663–670. [PubMed]
25. Hemmings HC, Jr, Yan W, Westphalen RI, Ryan TA. The general anesthetic isoflurane depresses synaptic vesicle exocytosis. Mol Pharmacol. 2005;67:1591–1599. [PubMed]
26. Choi JS, Tyrrell L, Waxman SG, Dib-Hajj SD. Functional role of the C-terminus of voltage-gated sodium channel Na(v)1.8. FEBS Lett. 2004;572:256–260. [PubMed]
27. John VH, Main MJ, Powell AJ, Gladwell ZM, Hick C, Sidhu HS, Clare JJ, Tate S, Trezise DJ. Heterologous expression and functional analysis of rat Nav1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23. Neuropharmacology. 2004;46:425–438. [PubMed]
28. Wood JN, Bevan SJ, Coote PR, Dunn PM, Harmar A, Hogan P, Latchman DS, Morrison C, Rougon G, Theveniau M, et al. Novel cell lines display properties of nociceptive sensory neurons. Proc Biol Sci. 1990;241:187–194. [PubMed]
29. Leffler A, Reiprich A, Mohapatra DP, Nau C. Use-dependent block by lidocaine but not amitriptyline is more pronounced in tetrodotoxin (TTX)-Resistant Nav1.8 than in TTX-sensitive Na+ channels. J Pharmacol Exp Ther. 2007;320:354–364. [PubMed]
30. Zhou X, Dong XW, Crona J, Maguire M, Priestley T. Vinpocetine is a potent blocker of rat NaV1.8 tetrodotoxin-resistant sodium channels. J Pharmacol Exp Ther. 2003;306:498–504. [PubMed]
31. Zimmermann K, Leffler A, Babes A, Cendan CM, Carr RW, Kobayashi J, Nau C, Wood JN, Reeh PW. Sensory neuron sodium channel Nav1.8 is essential for pain at low temperatures. Nature. 2007;447:855–858. [PubMed]
32. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85–100. [PubMed]
33. Lai J, Hunter JC, Porreca F. The role of voltage-gated sodium channels in neuropathic pain. Curr Opin Neurobiol. 2003;13:291–297. [PubMed]
34. Taheri S, Halsey MJ, Liu J, Eger EI, 2nd, Koblin DD, Laster MJ. What solvent best represents the site of action of inhaled anesthetics in humans, rats, and dogs? Anesth Analg. 1991;72:627–634. [PubMed]
35. Franks NP, Lieb WR. Selective actions of volatile general anaesthetics at molecular and cellular levels. Br J Anaesth. 1993;71:65–76. [PubMed]
36. Courtney KR. Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA. J Pharmacol Exp Ther. 1975;195:225–236. [PubMed]
37. Rush AM, Brau ME, Elliott AA, Elliott JR. Electrophysiological properties of sodium current subtypes in small cells from adult rat dorsal root ganglia. J Physiol. 1998;511:771–789. [PubMed]
38. Ouyang W, Herold KF, Hemmings HC., Jr Comparative effects of halogenated inhaled anesthetics on voltage-gated Na+ channel function. Anesthesiology. 2009;110:582–590. [PMC free article] [PubMed]
39. Ouyang W, Jih TY, Zhang TT, Correa AM, Hemmings HC., Jr Isoflurane inhibits NaChBac, a prokaryotic voltage-gated sodium channel. J Pharmacol Exp Ther. 2007;322:1076–1083. [PubMed]
40. Ragsdale DS, McPhee JC, Scheuer T, Catterall WA. Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science. 1994;265:1724–1728. [PubMed]
41. Fitzgerald EM, Okuse K, Wood JN, Dolphin AC, Moss SJ. cAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS. J Physiol. 1999;516:433–446. [PubMed]
42. Okuse K, Malik-Hall M, Baker MD, Poon WY, Kong H, Chao MV, Wood JN. Annexin II light chain regulates sensory neuron-specific sodium channel expression. Nature. 2002;417:653–656. [PubMed]
43. Hille B. Classical Mechanisms of Block, Ion Channels of Excitable Membranes, 3. Edition. Sunderland, MA: Sinauer Associates, Inc; 2001. pp. 504–538.
44. Nau C, Wang GK. Interactions of local anesthetics with voltage-gated Na+ channels. J Membr Biol. 2004;201:1–8. [PubMed]
45. Cummins TR, Waxman SG. Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury. J Neurosci. 1997;17:3503–3514. [PubMed]
46. Vedantham V, Cannon SC. The position of the fast-inactivation gate during lidocaine block of voltage-gated Na+ channels. J Gen Physiol. 1999;113:7–16. [PMC free article] [PubMed]
47. Abrahamsen B, Zhao J, Asante CO, Cendan CM, Marsh S, Martinez-Barbera JP, Nassar MA, Dickenson AH, Wood JN. The cell and molecular basis of mechanical, cold, and inflammatory pain. Science. 2008;321:702–705. [PubMed]
48. Roza C, Laird JM, Souslova V, Wood JN, Cervero F. The tetrodotoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice. J Physiol. 2003;550:921–926. [PubMed]
49. Tomi K, Mashimo T, Tashiro C, Yagi M, Pak M, Nishimura S, Nishimura M, Yoshiya I. Alterations in pain threshold and psychomotor response associated with subanaesthetic concentrations of inhalation anaesthetics in humans. Br J Anaesth. 1993;70:684–686. [PubMed]
50. Petersen-Felix S, Arendt-Nielsen L, Bak P, Roth D, Fischer M, Bjerring P, Zbinden AM. Analgesic effect in humans of subanaesthetic isoflurane concentrations evaluated by experimentally induced pain. Br J Anaesth. 1995;75:55–60. [PubMed]
51. O'Connor TC, Abram SE. Inhibition of nociception-induced spinal sensitization by anesthetic agents. Anesthesiology. 1995;82:259–266. [PubMed]
52. Jinks S, Antognini JF, Carstens E, Buzin V, Simons C. Isoflurane can indirectly depress lumbar dorsal horn activity in the goat via action within the brain. Br J Anaesth. 1999;82:244–249. [PubMed]
53. Kingery WS, Agashe GS, Guo TZ, Sawamura S, Davies MF, Clark JD, Kobilka BK, Maze M. Isoflurane and nociception: spinal alpha2A adrenoceptors mediate antinociception while supraspinal alpha1 adrenoceptors mediate pronociception. Anesthesiology. 2002;96:367–374. [PubMed]
54. Mitsuyo T, Dutton RC, Antognini JF, Carstens E. The differential effects of halothane and isoflurane on windup of dorsal horn neurons selected in unanesthetized decerebrated rats. Anesth Analg. 2006;103:753–760. [PubMed]
55. Cornett PM, Matta JA, Ahern GP. General anesthetics sensitize the capsaicin receptor transient receptor potential V1. Mol Pharmacol. 2008;74:1261–1268. [PubMed]